MedTrace Logo

Fatty Acids Omega -3 Diet Supplementation Efficiency and Safety Evaluation in Anorexia Nervosa

NCT01761942 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2013-01-07

No results posted yet for this study

Summary

The purpose of this study is to determine whether omega -3 fatty acids are effective and safe in treating anorexia nervosa.

Conditions

  • Anorexia Nervosa

Interventions

DIETARY_SUPPLEMENT

fatty acids preparation- eye-q

3x2 tablets daily by 70 days

Sponsors & Collaborators

  • Institute of Psychiatry and Neurology, Warsaw

    lead OTHER

Principal Investigators

  • Agnieszka Piróg-Balcerzak, MD · Institute of Psychiatry and Neurology, Warsaw

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
19 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2014-12-31
Completion
2014-12-31

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01761942 on ClinicalTrials.gov